Insider Transactions in Q4 2019 at Crispr Therapeutics Ag (CRSP)
Insider Transaction List (Q4 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2019
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+4.44%
|
$8,000
$1.81 P/Share
|
|
Dec 01
2019
|
Samarth Kulkarni Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
741
-0.45%
|
$52,611
$71.65 P/Share
|
|
Nov 19
2019
|
Pablo J Cagnoni Director |
SELL
Open market or private sale
|
Direct |
7,500
-100.0%
|
$465,000
$62.0 P/Share
|
|
Nov 19
2019
|
Pablo J Cagnoni Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+50.0%
|
$37,500
$5.59 P/Share
|
|
Nov 19
2019
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
33,618
-100.0%
|
$2,353,260
$70.0 P/Share
|
|
Nov 19
2019
|
Rodger Novak President |
BUY
Exercise of conversion of derivative security
|
Direct |
33,618
+50.0%
|
$470,652
$14.43 P/Share
|
|
Nov 19
2019
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
28,255
-4.52%
|
$1,893,085
$67.41 P/Share
|
|
Nov 19
2019
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Direct |
13,745
-100.0%
|
$920,915
$67.41 P/Share
|
|
Nov 12
2019
|
Pablo J Cagnoni Director |
SELL
Open market or private sale
|
Direct |
7,500
-100.0%
|
$412,500
$55.0 P/Share
|
|
Nov 12
2019
|
Pablo J Cagnoni Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+50.0%
|
$37,500
$5.59 P/Share
|
|
Oct 30
2019
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Direct |
21,000
-60.44%
|
$1,071,000
$51.89 P/Share
|
|
Oct 30
2019
|
Pablo J Cagnoni Director |
SELL
Open market or private sale
|
Direct |
7,500
-100.0%
|
$390,000
$52.0 P/Share
|
|
Oct 30
2019
|
Pablo J Cagnoni Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+50.0%
|
$37,500
$5.59 P/Share
|